| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Nov 24, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Head of U.S. Commercial | Sell | 7.5 | -28,229 | -30.73% | ✓ | $699.5K |
| Nov 14, 2025 | Nov 18, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Head of U.S. Commercial | Sell | 20.0 | -30,000 | -51.38% | ✗ | $753.3K |
| Mar 4, 2025 | Mar 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Head of U.S. Commercial | Sell | 28.8 | -6,181 | -9.57% | ✓ | $97.6K |
| Nov 20, 2024 | Nov 21, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, Head of U.S. Commercial | Sell | 7.5 | -19,388 | -30.54% | ✓ | $327.1K |